CorMedix (CRMD) Operating Income Growth (1y) (2011 - 2025)
CorMedix (CRMD) Operating Income Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1,386.07% |
| 10 | CorMedix | 4.93 Mn | -150.27 Mn | 107.31 Mn | 357.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 357.05% |
| Sep 30, 2025 | 1,661.93% |
| Jun 30, 2025 | 227.73% |
| Mar 31, 2025 | 220.48% |
| Dec 31, 2024 | 182.56% |
| Sep 30, 2024 | 68.59% |
| Jun 30, 2024 | -29.62% |
| Mar 31, 2024 | -51.62% |
| Dec 31, 2023 | -86.77% |
| Sep 30, 2023 | -50.35% |
| Jun 30, 2023 | -43.25% |
| Mar 31, 2023 | -56.66% |
| Dec 31, 2022 | -7.83% |
| Sep 30, 2022 | 18.72% |
| Jun 30, 2022 | -40.09% |
| Mar 31, 2022 | 2.47% |
| Dec 31, 2021 | -27.86% |
| Sep 30, 2021 | -29.70% |
| Jun 30, 2021 | 34.06% |
| Mar 31, 2021 | -28.49% |